Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics


Harvard Bioscience, Inc. (HBIO): $7.89

-0.16 (-1.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HBIO POWR Grades


  • Growth is the dimension where HBIO ranks best; there it ranks ahead of 99.49% of US stocks.
  • HBIO's strongest trending metric is Value; it's been moving down over the last 31 weeks.
  • HBIO ranks lowest in Momentum; there it ranks in the 15th percentile.

HBIO Stock Summary

  • Price to trailing twelve month operating cash flow for HBIO is currently 42.64, higher than 89.19% of US stocks with positive operating cash flow.
  • Over the past twelve months, HBIO has reported earnings growth of -115.6%, putting it ahead of only 17.35% of US stocks in our set.
  • In terms of volatility of its share price, HBIO is more volatile than 83.81% of stocks we're observing.
  • Stocks that are quantitatively similar to HBIO, based on their financial statements, market capitalization, and price volatility, are UFI, ESTA, CLNE, VG, and HLIT.
  • Visit HBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.harvardbioscience.com.

HBIO Valuation Summary

  • HBIO's price/sales ratio is 3.1; this is 13.89% lower than that of the median Healthcare stock.
  • HBIO's price/sales ratio has moved down 4.7 over the prior 243 months.
  • HBIO's price/sales ratio has moved down 4.7 over the prior 243 months.

Below are key valuation metrics over time for HBIO.

Stock Date P/S P/B P/E EV/EBIT
HBIO 2020-08-03 1.1 1.6 -18.0 -61.6
HBIO 2019-01-08 1.1 1.6 -26.4 -76.6
HBIO 2008-09-29 1.6 1.9 -88.3 184.0
HBIO 2007-03-29 1.9 2.0 -62.8 -1026.3
HBIO 2006-01-25 1.8 2.0 -6.0 -8.0
HBIO 2003-01-31 1.8 1.3 70.8 17.8

HBIO Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at 321.09%.
  • The 4 year price growth rate now stands at -11.78%.
  • Its 3 year price growth rate is now at -12.1%.
Over the past 30 months, HBIO's revenue has gone down $9,061,000.

The table below shows HBIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 105.318 7.497 -3.963
2020-12-31 102.1 9.331 -7.81
2020-12-31 102.1 9.331 -7.81
2020-09-30 102.088 9.061 -6.645
2020-06-30 105.469 10.622 -8.167
2020-03-31 111.745 8.906 -6.833

HBIO Price Target

For more insight on analysts targets of HBIO, see our HBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.75 Average Broker Recommendation 1.38 (Strong Buy)

HBIO Stock Price Chart Interactive Chart >

Price chart for HBIO

HBIO Price/Volume Stats

Current price $7.89 52-week high $8.55
Prev. close $8.05 52-week low $2.74
Day low $7.84 Volume 109,300
Day high $8.17 Avg. volume 231,726
50-day MA $7.61 Dividend yield N/A
200-day MA $5.59 Market Cap 315.26M

Harvard Bioscience, Inc. (HBIO) Company Bio


Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.


HBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

HBIO Latest Social Stream


Loading social stream, please wait...

View Full HBIO Social Stream

Latest HBIO News From Around the Web

Below are the latest news stories about Harvard Bioscience Inc that investors may wish to consider to help them evaluate HBIO as an investment opportunity.

Harvard Bioscience (HBIO) Reports Next Week: What to Know Ahead of the Release

Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 29, 2021

Global Perfusion Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Getinge, Medtronic, LivaNova, Terumo Medical, Xenios, Lifeline Scientific, XVIVO Perfusion, Repligen Corporation, Spectrum Laboratories, Merck, Harvard Bioscience, Ala Science

The report on Global Perfusion Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description contains a basic definition of []

Jumbo News | July 23, 2021

What Type Of Shareholders Make Up Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Registry?

The big shareholder groups in Harvard Bioscience, Inc. ( NASDAQ:HBIO ) have power over the company. Generally speaking...

Yahoo | July 20, 2021

Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET

HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

Intrado Digital Media | July 19, 2021

10 Best Stocks Under $10 to Buy Right Now

In this article, we will be looking at the 10 best stocks under $10 to buy right now. If you want to skip our detailed analysis on these companies, you can go directly to the 5 Best Stocks Under $10 to Buy Right Now. Investing in cheap stocks can lead to financial success given that […]

Yahoo | July 12, 2021

Read More 'HBIO' Stories Here

HBIO Price Returns

1-mo -4.13%
3-mo 13.04%
6-mo 64.72%
1-year 153.70%
3-year 37.22%
5-year 178.80%
YTD 83.92%
2020 40.66%
2019 -4.09%
2018 -3.64%
2017 8.20%
2016 -12.10%

Continue Researching HBIO

Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:

Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9074 seconds.